0001829126-21-000347.txt : 20210202 0001829126-21-000347.hdr.sgml : 20210202 20210202160651 ACCESSION NUMBER: 0001829126-21-000347 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 EFFECTIVENESS DATE: 20210202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inspyr Therapeutics, Inc. CENTRAL INDEX KEY: 0001421204 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388184 FILM NUMBER: 21581460 BUSINESS ADDRESS: STREET 1: 2629 TOWNSGATE RD, SUITE 215 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: (210) 479-8112 MAIL ADDRESS: STREET 1: 2629 TOWNSGATE RD, SUITE 215 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENSPERA INC DATE OF NAME CHANGE: 20071213 D 1 primary_doc.xml X0708 D LIVE 0001421204 Inspyr Therapeutics, Inc. 2629 TOWNSGATE ROAD SUITE 215 WESTLAKE VILLAGE CA CALIFORNIA 91361 (818) 597-7552 DELAWARE GenSpera, Inc. GENSPERA INC Corporation true Michael Cain 2629 Townsgate Road Suite 215 Westlake Village CA CALIFORNIA 91361 Executive Officer Director Scott Ogilvie 2629 Townsgate Road Suite 215 Westlake Village CA CALIFORNIA 91361 Director Claire Thom 2629 Townsgate Road Suite 215 Westlake Village CA CALIFORNIA 91361 Director Pharmaceuticals Decline to Disclose 06b false 2020-10-05 false true true true 65,000,000 common shares and 8,000 Series F Preferred Shares pursuant to termination of license false 0 0 0 0 Issuance in exchange for termination of existing licensing agreement false 1 0 0 0 false Inspyr Therapeutics, Inc. /s/ Michael Cain Michael Cain CEO 2021-02-02